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ACKGROUND: GM1 gangliosidosis is a rare disease due to mutations in the GLB1 gene and
utosomal recessive deﬁciency of b-galactosidase. There is considerable overlap between
classical phenotypes and clinical and imaging ﬁndings, which are often difﬁcult to
interpret. PATIENT: The patient in this study had dysmorphism, dysostosis, progressive
dystonia, and T2 hypointensity in the basal ganglia. Partially similar clinical and radiologic
ﬁndings were described previously in two reports. CONCLUSIONS: T2 hypointensity in the
globus pallidus should, in the appropriate clinical setting, lead to consideration of the
diagnosis of GM1 gangliosidosis.
 2013 Elsevier Inc. All rights reserved.Introduction
GM1 gangliosidosis is a rare disease with an inci-
dence estimated between 1 in 100,000 or 200,000 live
births. Autosomal recessive deﬁciency of b-galactosi-
dase due to a mutation in the GLB1 gene is present not
only in this disorder but also in Morquio type-B
disease [1].
Classically, GM1 gangliosidosis is divided into subtypes
with different ages of onset and diverse neurological
and systemic features. However, a signiﬁcant number of
patients can share characteristics of different types. There
may also be overlap between GM1 gangliosidosis and
Morquio phenotypes [1-3]. Neuroimaging in GM1 gan-
gliosidosis has been reported in a limited number of
patients [2,4-6].
Nonspeciﬁc white matter hyperintensity, thalamic hypo-
intensity on T2-weighted imaging, delayed myelination, and
T2 hyperintense signal in the putamina were reported
previously.: Dr. Vieira; Hospital de
ntral; Rua Jacinta Marto;
ll rights reserved.Two reports previously described T2 hypointensity in the
globus pallidus [5,6].
Case Report
This 12-year-old boy born of healthy, nonconsanguineous parents
had a history of slowly progressive psychomotor regression and invol-
untary movements since the age of four.
On neurological examination he was microcephalic and had
convergent strabismus, severe orofacial dystonia, dysarthria, and limb
and trunk dystonia. He exhibited facial dysmorphism (frontal bossing,
wide nasal root, large and low set ears), pectus carinatum, short stature,
and dorsal kyphosis. Corneal opacities were not present, nor were the
liver and spleen enlarged.
Skeletal radiographies showed osteonecrosis of the femoral head and
hypoplastic body of the tenth dorsal vertebra.
Magnetic resonance imaging revealed a hypointense T2 signal in the
substantia nigra and in the globus pallidus, with marked hypointensity
in susceptibility-weighted imaging and slight T2 hyperintensity in the
posterior part of the putamen (Figs 1 and 2). Brain calciﬁcations were not
seen on computed tomography scan (not shown).
Beta-galactosidase deﬁciency was demonstrated subsequently (8
nm/hr/mg protein; reference value: 73-585) and a homozygous muta-
tion in the GLB1 gene: c.1313G>A; (p.G438E), exon 13.
Discussion
Dysmorphism and dysostosis are features of type-1
(infantile) and of Morquio type-B disease, while slowly
Figure 1. Susceptibility weighted imaging showing hypointense T2 signal in the substantia nigra (right) and in the globus pallidus (left) (arrows).
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gliosidosis; nevertheless, individual patients often have
clinical and imagiologic features that overlap between the
classical phenotypes [1].Figure 2. T2-weighted image showing hypointense signal in the globus pal-
lidus and slight hyperintensity in the posterior part of the putamen (arrows).Our patient exhibited the homozygous mutation
c.1313G>A; (p.G438E), which has been reported in
patients with Morquio type-B and with type-3 GM1
phenotypes [1]. Caciotti et al. [1] reported one
patient (patient number 20 in their series) with the
same mutation and a phenotype very similar to that
in this report, but they did not mention imaging
ﬁndings.
Tanaka et al. [5] reported a girl with a mutation in
exon 2, dysmorphism, dysostosis, and slowly progres-
sive dystonia since early childhood. Two patients re-
ported by De Grandis et al. [6] had dysostosis: one had
dystonia and ataxia and the other dystonia and
spasticity, apparently also of childhood onset, but
dysmorphism was not reported. Their genotype was
not reported. MRI ﬁndings in this case study and in
those reported by Tanaka et al. and De Grandis et al.
are identical: T2 pallidal hypointensity and T2 hyper-
intensity in the posterior putamen were seen;
iron deposition in the substantia nigra was not
reported.
T2 hypointensity due to iron deposition in the basal
ganglia is found in normal adults but not usually in
children or adolescents. Neuronal brain iron accumula-
tion is responsible for the shortening of T2 relaxation
time in pantothenate kinaseeassociated neuro-
degeneration, infantile neuroaxonal dystrophy, and
neuroferritinopathy. In pantothenate kinaseeassociated
neurodegeneration, hypointensity occurs besides the
globus pallidus in the substantia nigra but later in the
course of the disease.
In some lysosomal diseases like fucosidosis and GM1
gangliosidosis, iron overload may result from a defect in
intralysosomal recycling. The Table lists the differential
diagnosis for neuronal brain iron accumulation in
children.
Table. Differential diagnosis of T2 hypointensity (iron deposition) in the globus pallidus in children
Diagnosis Clinical Features MRI Findings
Pantothenate kinase-associated neurodegeneration (PKAN) Dystonia, dysarthria; pigmentary retinopathy Iron deposition in GP; eye of the
tiger sign
PLA2G6-associated neurodegeneration (PLAN);
Infantile neuroaxonal dystrophy (INAD)
Psychomotor regression; ataxia; hypotonia Iron deposition in GP; cerebellar
atrophy
Mitochondrial membrane protein-associated
neurodegeneration (MPAN)
Spasticity, dystonia, cognitive decline Iron deposition in GP and SN
Fatty-acid hydroxylase-associated neurodegeneration
(FAHN)
Dystonia, spasticity, dysarthria Iron deposition in GP and SN,
cerebellar and brainstem atrophy,
leukoencephalopathy
Kufor-Rakeb syndrome Juvenile Parkinsonism Iron deposition in caudate and
lenticular nuclei
GM1 gangliosidosis Dystonia; dysmorphism; dysostosis Iron deposition in GP
Fucosidosis Psychomotor regression, spasticity, coarse
facial features
Leukoencephalopathy; T2
hypointensity in the GP
Abbreviations:
GP ¼ Globus pallidus
MRI ¼ Magnetic resonance image
SN ¼ Substantia nigra
J.P. Vieira et al. / Pediatric Neurology 49 (2013) 195e197 197In the clinical setting of dysostosis and dystonia, the
ﬁnding of T2 hypointense pallidal lesions should lead to
consideration of GM1 gangliosidosis.
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